RedHill Biopharma Presents New Data from Talicia®'s Phase 3 Studies at ACG 2020 Focused on Achieving Successful First-Line Treatment in H. pylori Eradication
Stock Information for Redhill Biopharma Ltd.
Loading
Please wait while we load your information from QuoteMedia.